[1]
Chu, D., Stephenson, B., Lee, J., Bannister, B., Hickey, C., Westley, T. and Zirwas, M. 2024. Clinical Efficacy and Patient Reported Impacts of Roflumilast Foam 0.3% in Seborrheic Dermatitis: An Analysis of STRATUM Data for Patients Unresponsive or Intolerant to Topical Corticosteroids. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s397. DOI:https://doi.org/10.25251/skin.8.supp.397.